First Databank
Improving Access to Prescription Drug Information
Pages
5
Time to read
15 mins
Publication
Language
English
Pages
5
Time to read
15 mins
Publication
Language
English
This white paper discusses the challenges and solutions related to accessing prescription drug information, particularly focusing on out-of-pocket costs and educational resources for patients. It outlines how medication nonadherence significantly impacts patient outcomes and healthcare costs, with statistics indicating that cost-related nonadherence can lead to higher mortality rates and substantial economic burdens. The paper highlights the role of Real-Time Pharmacy Benefit (RTPB) information, which remains largely inaccessible to consumers due to technical barriers. It emphasizes the need for improved access to reliable drug pricing information and educational materials to empower patients in making informed decisions about their medications. The FDB Vela™ ePrescribing network is presented as a solution to enhance transparency and facilitate better communication between patients, providers, and pharmacies. By leveraging technology, the network aims to provide consumers with the necessary tools to understand their medication costs and adhere to their treatment plans effectively.